Autoimmune Bullous Skin Diseases

48 ta ish

The new differential diagnostic test for the lichenoid drug eruption
A. S. Sidikov, D. V. Zaslavsky, A. I. Sadykov +10
MaqolaOral Health Pathology and TreatmentDermatologic Therapy20203 iqtibos
ABI
PSORIAZ KASALLIGINING PAYDO BO‘LISH BOSQICHLARI, TURLARI VA UNI XALQ TABOBATI YO‘LI BILAN DAVOLASH
Yusubjon Hakimovich Xolboyev, Adxamjon Begishovich Pakirdinov, Abduxamit Gafurovich Maxsumov +1
MaqolaAutoimmune Bullous Skin DiseasesJournal of Chemistry of Goods and Traditional Medicine20221 iqtibos
ABI
Pemphigus in pregnancy
Amrinder J. Kanwar, Surrinder Kaur, Anil Abraham +1
MaqolaAutoimmune Bullous Skin DiseasesAmerican Journal of Obstetrics and Gynecology19890 iqtibos
ABI
Sensitivity of skin microflora to antibacterial medications administered to patients with different status of HIV.
Bakhadir Azizov, G. A. Ismailova
MaqolaHidradenitis Suppurativa and TreatmentsPubMed20110 iqtibos
ABI
Licofuranocoumarin
Shakhnoza S. Azimova, Valentina I. Vinogradova
BobAutoimmune Bullous Skin Diseases20120 iqtibos
ABI
Folimidine
Shakhnoza S. Azimova, Marat S. Yunusov
BobOral and gingival health research20120 iqtibos
ABI
Difillinin
Shakhnoza S. Azimova, Валентина И. Виноградова
BobAutoimmune Bullous Skin Diseases20120 iqtibos
ABI
Glucoisoliquiritin apioside
Shakhnoza S. Azimova, Валентина И. Виноградова
BobPharmacological Effects of Natural Compounds20120 iqtibos
ABI
Alopecurone-D
Shakhnoza S. Azimova, Valentina I. Vinogradova
BobCancer Treatment and Pharmacology20120 iqtibos
ABI
Polygalacin D2
Shakhnoza S. Azimova
BobCoagulation, Bradykinin, Polyphosphates, and Angioedema20120 iqtibos
ABI
Liquiritigenin
Shakhnoza S. Azimova, Валентина И. Виноградова
BobPharmacological Effects of Natural Compounds20120 iqtibos
ABI
Intebrinine
Shakhnoza S. Azimova, Marat S. Yunusov
BobAutoimmune Bullous Skin Diseases20120 iqtibos
ABI
Cyclopassifloside II
Shakhnoza S. Azimova
BobAutoimmune Bullous Skin Diseases20120 iqtibos
ABI
Foliminine
Shakhnoza S. Azimova, Marat S. Yunusov
BobAutoimmune Bullous Skin Diseases20120 iqtibos
ABI
Isocorybulbine
Shakhnoza S. Azimova, Marat S. Yunusov
BobChronic Lymphocytic Leukemia Research20120 iqtibos
ABI
Kuraridinol
Shakhnoza S. Azimova, Валентина И. Виноградова
BobChemotherapy-related skin toxicity20120 iqtibos
ABI
Brevicarine
Shakhnoza S. Azimova, Marat S. Yunusov
BobPhytochemical Studies and Bioactivities20120 iqtibos
ABI
Turcomanine
Shakhnoza S. Azimova, Marat S. Yunusov
BobCancer Treatment and Pharmacology20120 iqtibos
ABI
Pachydermoperiostosis Masquerading as Acromegaly
М.М. Карімова, Zamira Halimova, Yulduz Urmanova +3
MaqolaHypertrophic osteoarthropathy and related conditionsJournal of the Endocrine Society20170 iqtibos
ABI
FROM PATHOLOGICAL PROCESSES TO PATHOGENESIS OF MEdICALLY ALLERGY
Iskandar Mavlyanov, A H Ashirmetov, Z.I. Mavlyanov
MaqolaDrug-Induced Adverse ReactionsHERALD of North-Western State Medical University named after I I Mechnikov20170 iqtibos
ABI
The Approach to Managing the Patients with Idiopathic Thrombocytopenic Purpura: A Case-Control Study
Gaybulla Mustafakulov
MaqolaPlatelet Disorders and TreatmentsIndian Journal of Forensic Medicine & Toxicology20200 iqtibos
ABI
A clinical case of an immunosuppressive generalized form of Kaposi's sarcoma in a patient with pemphigus vulgaris
Evelina Koldarova, Bahrambek Mukhamedov, Aziz Sh. Aliev
MaqolaViral-associated cancers and disordersJournal of Clinical Medicine of Kazakhstan20220 iqtibos
ABI
[A man with a rare disfiguring cutaneous manifestation of sarcoidosis].
Caro Mo, G. E. van der Kraaij, R.J.T. van der Leest
MaqolaSarcoidosis and Beryllium Toxicity ResearchPubMed20220 iqtibos
ABI
Structure of comorbidity in idiopathic thrombocytopenic purple
Kattabek Makhmatovich Abdiev, Feruza Khaydarovna Mamatkulova, Khudoyor Makhmudovich Shomirzaev
MaqolaPlatelet Disorders and TreatmentsACADEMICIA An International Multidisciplinary Research Journal20220 iqtibos
ABI
IMMUNOLOGICAL ASPECTS OF HERPETIC STOMATITIS IN WOMEN DURING PREGNANCY
Yuldasheva Nasiba Alisherovna, Kamilova Adiba Zakirzhonovna
MaqolaUrticaria and Related ConditionsZenodo (CERN European Organization for Nuclear Research)20230 iqtibos
ABI